The objectives of this study were to assess the stability of a 1 mg/ml
oral midazolam solution elaborated by our Hospital Pharmacy Service,
and to confirm its clinical effect in pre-surgical paediatric patients
. The solution's stability was tested by determining its pH and its UV
-visible absorption spectrum at room temperature for up to 60 days. A
high performance liquid chromatography method was used to confirm it.
There was no significant change in pH value of either the test or a co
ntrol solution. No loss of midazolam could be detected during the test
. The Anaesthesiology Service assessed the sedation quality (very good
, good, bad) and the venous puncture response, 20 minutes after the ad
ministration of 0.3 mg/kg of an oral midazolam solution. Twenty childr
en were examined (age: 4-7 years). In addition, the haemodynamic and v
entilatory functions were I evaluated.